Expertise in
9
conditions

Fanny Rialland

Nantes, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
Nantes, FR 

Overview

Fanny Rialland practices practicing medicine in Nantes, France.

Ms. Rialland is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Severe Congenital Neutropenia, Leukemia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Splenectomy.

She is actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Nantes, France
Other Locations
CHU Grenoble Alpes
Grenoble, France
Paris, France
Montpellier, 34090, France
Rennes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: September 04, 2026
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Enrollment Status: Completed
Publish Date: April 05, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

73 Total Publications

Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French Experience.
Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French Experience.
Journal: Transplantation and cellular therapy
Published: April 13, 2026

Frequently Asked Questions about Fanny Rialland

Is Fanny Rialland a top-rated expert for Severe Congenital Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Fanny Rialland is classified as an Distinguished expert for Severe Congenital Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fanny Rialland participate in research or clinical trials?

Yes. Fanny Rialland has published 73 articles and abstracts on conditions like Severe Congenital Neutropenia. You can view a list of Fanny Rialland's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Rialland's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile